M
Martin D. McCarter
Researcher at Anschutz Medical Campus
Publications - 235
Citations - 11114
Martin D. McCarter is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Cancer & Melanoma. The author has an hindex of 55, co-authored 217 publications receiving 9386 citations. Previous affiliations of Martin D. McCarter include Cornell University & Harvard University.
Papers
More filters
Journal ArticleDOI
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
Ronald P. DeMatteo,Karla V. Ballman,Cristina R. Antonescu,Robert G. Maki,Peter W.T. Pisters,George D. Demetri,Martin E. Blackstein,Charles D. Blanke,Margaret von Mehren,Murray F. Brennan,Shreyaskumar Patel,Martin D. McCarter,Jonathan Polikoff,Benjamin R. Tan,Kouros Owzar +14 more
TL;DR: Adjuvant imatinib therapy is safe and seems to improve recurrence-free survival compared with placebo after the resection of primary gastrointestinal stromal tumour.
Journal ArticleDOI
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren,R. Lor Randall,Robert S. Benjamin,Sarah Boles,Marilyn M. Bui,Ernest U. Conrad,Kristen N. Ganjoo,Suzanne George,Ricardo J. Gonzalez,Martin J. Heslin,John M. Kane,Henry B. Koon,Joel L. Mayerson,Martin D. McCarter,Sean V. McGarry,Christian F. Meyer,Richard J. O'Donnell,Alberto S. Pappo,I. Benjamin Paz,Ivy A. Petersen,John D. Pfeifer,Richard F. Riedel,Scott M. Schuetze,Karen D. Schupak,Herbert S. Schwartz,William D. Tap,Jeffrey D. Wayne,Mary Anne Bergman,Jillian L. Scavone +28 more
TL;DR: This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
Journal ArticleDOI
Effects of limited work hours on surgical training
TL;DR: In this paper, the authors compared parameters of resident education, patient care, and resident quality of life before and after institution of a strict 80-hour work week resident training schedule.
Journal ArticleDOI
Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial
Christopher L. Corless,Karla V. Ballman,Cristina R. Antonescu,Violetta Kolesnikova,Robert G. Maki,Peter W.T. Pisters,Martin E. Blackstein,Charles D. Blanke,George D. Demetri,Michael Heinrich,Margaret von Mehren,Shreyaskumar Patel,Martin D. McCarter,Kouros Owzar,Ronald P. DeMatteo +14 more
TL;DR: The findings show that tumor size, location, and mitotic rate, but not tumor genotype, are associated with the natural history of GIST, and imatinib therapy was associated with higher RFS.
Journal ArticleDOI
ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
Yuchun Luo,Katiuscia Dallaglio,Ying Chen,William A. Robinson,Steven E. Robinson,Martin D. McCarter,Jianbin Wang,Rene Gonzalez,David C. Thompson,David A. Norris,David A. Norris,Dennis R. Roop,Vasilis Vasiliou,Mayumi Fujita,Mayumi Fujita +14 more
TL;DR: The existence of human melanoma cells that fulfill the criteria for CSCs (self‐renewal and differentiation) by serially xenotransplanting cells into nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice is demonstrated and it is implicate that ALDH isozymes are not only biomarkers of C SCs but also attractive therapeutic targets forhuman melanoma.